ACG

Despite warnings and concerns, the evidence points to this bottom line: PPIs are relatively safe over the long term.

Ulcerative colitis is primarily a mucosal disease, and other changes appear to be secondary to this process. By contrast, Crohn disease, or granulomatous colitis, involves the whole thickness of the bowel wall.

Age-based screening recommendations for chronic hepatitis C virus infection targeted to Americans born between 1945 and 1965 were announced by the CDC.

Is the increased risk of IBD due to pollution, a too-clean home, or antibiotics? Or none of the above?

Did you know: The hepatitis B virus is the only human virus that is routinely tested for by measuring a marker, or “footprint,” of the virus in the blood? Here, an explanation for this and 4 more things you need to know about HBV.

Fergus Shanahan, MD, FACG, summarizes his session at ACG 2011, "Probiotics: Are They Ready for Prime Time?"

Christopher Pleyer, MD, from the Mayo Clinic, Rochester, MN, summarizes his part in the plenary session "Observer Bias in the Diagnosis of Gastroesophageal Reflux Disease and Functional Dyspepsia" at ACG 2011. Distinguishing GERD from other upper GI problems is crucial, he explains.

Is obesity really leading to an increase in GERD? Or, has GERD just become a catch-all phrase for all sorts of upper GI distress? Has GERD become the new "dyspepsia"? G. Richard Locke, MD, FACG, from the Mayo Clinic, Rochester, MN, discusses his findings as presented at the ACG 2011 program.

Clostridium difficile infection is a serious, life-threatening nosocomial infection that can follow on the heels of broad-spectrum antibiotic use. It affects over 500,000 Americans annually, with 15,000 deaths. Infection recurs in 15% to 25% of those initially treated successfully; infection subsequently redevelops in 40% to 50% of those an initial recurrence.

If ACG 2011 had a recurrent theme, it was nicely summed up in this lecture: probiotic treatments are coming. Scientific evidence is accumulating for this approach, and patients will likely embrace it as a “natural” remedy. Primary care physicians should carefully follow this emerging trend-it holds promise for some of our most challenging patients with chronic disease.